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Summary
Ultrasound imaging of the lung and associated tissues may play an important role in the management of patients
with COVID-19–associated lung injury. Compared with other monitoring modalities, such as auscultation or
radiographic imaging, we argue lung ultrasound has high diagnostic accuracy, is ergonomically favourable and
has fewer infection control implications. By informing the initiation, escalation, titration andweaning of respiratory
support, lung ultrasound can be integrated into COVID-19 care pathways for patients with respiratory failure.
Given the unprecedented pressure on healthcare services currently, supporting and educating clinicians is a key
enabler of the wider implementation of lung ultrasound. This narrative review provides a summary of evidence
and clinical guidance for the use and interpretation of lung ultrasound for patients with moderate, severe and
critical COVID-19–associated lung injury. Mechanisms by which the potential lung ultrasound workforce can be
deployed are explored, including a pragmatic approach to training, governance, imaging, interpretation of
images and implementation of lungultrasound into routine clinical practice.
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Introduction
Ultrasound imaging of the lung and associated tissues may
help inform clinical decision-making for patients with
coronavirus disease 2019 (COVID-19) and management of
their associated respiratory failure and lung injury. This is
facilitated in part by the typical sonographic characteristics
of COVID-19–associated lung injury during disease
progression and recovery [1]. Although there exists much
evidence to support the clinical value of lung ultrasound [2],
practice is underpinned through education, competency
and associated governance procedures [3]. As with other
point-of-care ultrasound areas, examinations should be
conducted to answer a focused clinical question and
procedures should be aligned with agreed national and
local standards [4, 5].
The COVID-19 pandemic has led to unprecedented
pressure on healthcare services, particularly care pathways
for all critically ill patients [6]. The existing lung ultrasound
workforce can easily be upscaled and upskilled through
education on the principles of lung ultrasound in patients
with COVID-19. This narrative review provides a summary of
theseprinciples and how lungultrasoundmoregenerally can
be integrated into the COVID-19 care pathway. We present
possible mechanisms for pragmatic training in the use of
lung ultrasound which may be achievable, despite the
unprecedenteddemandonclinical services.
Methods
We searched the CENTRAL, EMBASE and Web of Science
databases for all articles published between 1 November
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Table 1 Summary of retrieved evidence (alphabetical order by first author).
Author
[reference]
Article
type
Peer
reviewed
Number
of patients
Clinical
setting
Patient
population
Scanning
protocol
Transducer
type
Sonographic
elements/observations Recommendations
Buonsenso
et al. [7]
Letter Yes Not
reported
Hospital Children Not
reported
Linear
wireless
Recommendations for
lung ultrasound
to reduce SARS-CoV-2
transmission.
Avoid the use of
stethoscopes, chest
radiographs andCT to
reduce cross-infection
rates.
Buonsenso
et al. [8]
Case
report
Yes 1 Emergency
Department
Adult 12 areas Convex
Wireless
Bilateral involvement;
irregular pleura;
confluent B-lines; small
consolidations and
spared areas.
Use of lung ultrasound
tominimise number of
clinicians that patient is
exposed to and triage
high/low-risk patients.
A portable device is
easier to clean.
Corradi
et al. [9]
Letter Yes Not
applicable
Not reported Not
reported
Not
reported
Not reported Opinion onquantification
of B-lines relevant to
patients withCOVID-19.
Visual estimation of B-
line number and
frequency has high
inter- and intra-
observer variability.
Huang
et al. [1]
Case
series
No 20 Emergency
Department
Adults 12 areas Convex
or linear
Bilateral involvement;
posterior
and inferior involvement;
coalescent
B-lines; irregular pleura;
small consolidations;
air bronchograms;
and small pleural
effusions.
Lung characteristics of
patients withCOVID-
19 are ideal to image
with ultrasound.
Moro
et al. [10]
Clinical
recomm-
endation
Yes Not
reported
Not reported Pregnant
women
Not
reported
Convex
or linear
Thickened/irregular
pleura; spared areas;
small consolidations;
lobar consolidations; and
air bronchograms.
Tips include: set focus
on pleural line; to view
the pleura, reduce the
gain; scan in sitting or
side lying to avoid
prone lying.
Peng
et al. [11]
Letter Yes Not
reported
Critical care Critically
unwell
adults
12 areas Not
reported
Thickened/irregular
pleura; variety
of B-line patterns; non-
translobar
and translobar
consolidation; small
consolidations; air
bronchograms;
andpleural effusions
(rare).
Use of lung ultrasound
to track disease
evolution;monitor
lung recruitment;
response to prone
position;management
of extracorporeal
membrane
oxygenation; and
guideweaning and
liberation from
mechanical ventilation.
Poggiali
et al. [12]
Letter Yes 12 Emergency
Department
Adults Not
reported
Not
reported
Bilateral involvement;
B-lines; spared areas;
and small consolidations,
mainly posteriorly.
Recommends the use of
lung ultrasound in the
Emergency
Department for
patients withCOVID-
19.
Soldati
et al. [13]
Letter Yes Not
reported
Emergency
Department,
wards, and
critical care
Not
reported
16 areas Convex
or linear
Bilateral involvement,
confluent B-lines;
multiple areas of B-lines;
small consolidations;
large consolidation in
dependent areas;
and air bronchograms.
Use of lung ultrasound
to triage at home and
pre-hospital; diagnose
COVID-19; prognostic
stratification; track
evolution towards
consolidation; guide
mechanical ventilation
andweaning; and
monitor the effects of
therapeutic
interventions.
Soldati
et al. [14]
Clinical
recom-
mendation
Yes Not
reported
Wards and
critical care
Adults 14 areas Convex
or linear
An expert consensus
proposal for lung
ultrasound
scanning protocol in
patients withCOVID-19.
Tips include: use a hand-
held device and set the
focus on the pleural
line.
(continued)
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2019 and 1 April 2020. The following MeSH key words were
used: ‘lung’; ‘chest’; ‘pulmonary’; ‘pulmo*’; ‘thorax’; ‘thora*’;
‘ultrasound’; ‘sonography’; ‘ultraso*’; ‘sonog*’; ‘COVID*’;
and ‘SAR-CoV-2’. This yielded 11 full-text papers (Table 1).
Due in part to the rapid emergence of the COVID-19
pandemic, evidence in the published literature to guide
the use of lung ultrasound in COVID-19 is sparse. Letters
comprised the majority of publications (5/11), with two
case reports and three clinical recommendation papers.
The case series was a retrospective analysis of ultrasonic
features of non-critical patients with COVID-19 and was
published in a non-peer–reviewed journal. Five
publications [7, 8, 10, 13, 14] were written by the same
authorship group and the emphasis of their observations
is similar.
In the hierarchy of empirical evidence, all
publications identified by our search were deemed to
be weak [17]. This lack of high-quality evidence
published in peer-reviewed journals presents a challenge
to the formulation of recommendations. Consequently,
we also searched for publications from professional and
healthcare organisations.
Current impact on healthcare provision
Severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), which causes COVID-19, was declared a ‘Public
Health Emergency of International Concern’ on 30
January 2020 by the World Health Organization (WHO)
[18]. At the time of writing, global SARS-CoV-2
infections are in the hundreds of thousands and death
rates are accelerating, placing enormous demands on
healthcare provision [6]. As such, healthcare provision
needs to be responsive and adaptive. Examples of
pragmatic approaches include a recent guide on
methods for developing rapid guidelines on Covid-19
[19], a COVID-19 critical care rapid guideline [20] and
consensus guidelines for managing the airway in
patients with COVID-19 [21].
The role of lung ultrasound
Common initial symptoms of COVID-19 are fever, cough
and dyspnoea, with a wide spectrum of severity [22].
There are indications that 80% of patients have mild
symptoms but approximately 14% experience moderate
to severe disease with 5% becoming critically ill [23]. Of
the 19% of patients that contract COVID-19 and require
hospitalisation, almost all present with very distinctive
clinical characteristics that progress in a similar way on
computed tomography and ultrasound imaging [1, 24].
However, many traditional tools used for clinical
examination and decision-making are of limited utility in
a COVID-19 patient care pathway.
Despite using dedicated stethoscopes for individual
patients as per WHO guidance [25], auscultation presents a
high risk of nosocomial transmission [26]. The risk of
transporting critically unwell patients for a computed
tomography scan followed by the necessary
decontamination procedures makes this form of imaging
risky and time consuming [11]. The use of portable chest
radiographs also raises the issue of contamination, unless a
dedicated machine is reserved for cohorted patients. In
addition, chest radiographs correlate poorly with the clinical
picture as compared with computed tomography and
ultrasound imaging [27].
During COVID-19 disease progression, changes in the
lung parenchyma begin in the distal regions of the lung and
progress proximally. There are ‘ground glass’ opacities and
‘crazy paving’ changes seen on computed tomography
imaging in the early phases, and larger consolidations in the
basal or dependent lung regions later in the disease course
[24]. The regions most frequently affected are the right
middle and lower lobes followed by the left upper lobe [27].
The histopathology of the COVID-19 pneumonia
progresses in the distal regions of the lung and is
characterised by alveolar damage and oedema, interstitial
thickening and gravitational consolidations [13]. The
pathological progression of COVID-19 pneumonia is
Table 1 (continued)
Author
[reference]
Article
type
Peer
reviewed
Number
of patients
Clinical
setting
Patient
population
Scanning
protocol
Transducer
type
Sonographic
elements/observations Recommendations
Thomas
et al. [15]
Case
report
Yes 1 Ward and
critical care
Adult Not
reported
Convex Multifocal B-lines; pleural
thickening; and
small consolidations.
Lung ultrasoundmay be
useful to assess
patients withCOVID-
19.
Vetrugno
et al. [16]
Clinical
recom-
mendation
Yes Not
reported
Critical care Adults 12 areaLUS
score
Convex Confluent B-lines; pleural
thickening/disruption;
and small consolidations.
Use of lung ultrasound
to diagnose and
monitor;monitor
patient trajectory; and
reduce the need for
radiographic imaging.
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therefore well suited to a surface imaging technique such as
lung ultrasound [1] (Fig. 1).
To address contamination concerns, the UK
Intensive Care Society has published guidance on the
decontamination of ultrasound equipment for COVID-19
patients [28]. As the disease progresses and
characteristics develop, COVID-19 is associated with the
sonographic appearances of pleural line irregularities
and B-line artefacts, which are caused by interstitial
thickening and inflammation, and increase in number
with severity. Small consolidations also increase in
frequency and size [11]. According to the WHO [28],
patients with COVID-19 requiring hospitalisation for
moderate–severe disease will require supplementary
oxygen and regular monitoring that facilitates early
recognition and escalation of the deteriorating patient.
Recommendations are that patients receiving respiratory
support should be monitored closely for clinical
deterioration [30] and serial lung ultrasound imaging
may help inform this [31].
As with many areas of ultrasound imaging and
interpretation, the identification, quantification and
communication of the nature of B-lines is subjective and
may be open to interpretation [9, 14]. The larger the number
of regions scanned, the greater the likelihood of a
representative picture of overall organ involvement.
However, experience is required for the operator to
generate high-quality and reproducible images, and the
imaging of many regions is time consuming. In this regard,
we recommend a pragmatic approach depending on the
level of operator experience and the requirements of the
clinical team. The use of six-zone scanning would provide a
focused and rapid picture of involvement of key regions of
the lung [32].
Where time allows, use of the 12-zone lung ultrasound
score [33] provides a potential mechanism to bring a
degree of objectivity to quantifying the level of involvement,
as a comprehensive whole-organ assessment. In addition, it
allows for communication of findings between serial scans,
different operators and different care settings, so that
changes can be better quantified and communicated. As
such, these would be the realm of more experienced lung
ultrasound practitioners, with minimal additional training
[34]; although only where time allows.
Figure 1 Sonographic characteristics ofmoderate, severe and critical pleural and parenchymal changes in patients with
COVID-19.
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Supporting existing lung ultrasound
practitioners
Existing lung ultrasound practitioners are those clinicians
who have undertaken and formally demonstrated lung
ultrasound competency in the care of patients with
respiratory failure. Ideally, they would have successfully
gained accreditation following training in lung ultrasound
such as Focused Ultrasound in Intensive Care (FUSIC)
accreditation. These clinicians would regularly use lung
ultrasound to inform clinical decision-making and the care
of such patients within a structure that aligns with all relevant
clinical and governance considerations. Clinicians include
but are not limited to doctors, physiotherapists and
advanced critical care practitioners.
Lung ultrasound may allow operators and clinicians to
determine where a patient is on the clinical spectrum of
COVID-19–associated lung injury (Table 2) [35]. Patients are
grouped according to the severity of COVID-19–associated
respiratory failure: moderate, severe or critical [29].
Although these groupings might broadly align with the
clinical setting (e.g. ward, high dependency unit or intensive
care unit), grouping according to the level of respiratory
compromise allows for transferability of information
regardless of the care pathway configuration or care setting.
Inevitably, these patients may have comorbidities and/or
other COVID-19–related systemic involvement. Lung
ultrasound in these patients is solely with respiratory
function in mind. In all cases, correlation with clinical
presentation is required and sonographic findings must
never be the sole indicator for initiating, titrating, escalating
and/or weaning treatment.
The lung ultrasound score is one potential mechanism
to objectively grade COVID-19–associated lung injury. The
sonographic artefact patterns seen on lung ultrasound may
also be used to monitor the degree of lung aeration at the
bed-side with effects seen from positive end expiratory
pressure recruitment [33, 36] and spontaneous breathing
trials during liberation from mechanical ventilation [37].
Across 12 scanning zones, (six on each hemithorax) to a
maximum score of 36, the four lung ultrasound aeration
patterns (scored 0–3) are normal pattern (A-lines or non-
significant B-lines), generating zero points; significant B-
lines (≥3 per rib space), generating one point; coalescent B-
lines with or without small consolidations, generating two
points; and consolidation, generating three points [31].
Intra- and inter-rater reliability has yet to be fully explored
with the lung ultrasound scoring system [38], but this 0–36-
point scoring system may have the potential to monitor the
deterioration or recovery of lung aeration in patients with
COVID-19 and to guide the administration of ventilation
techniques, positive end expiratory pressure, prone
positioning or any combination thereof.
Table 2 A simplifieddescription of where in theCOVID-19 patient care pathway lung ultrasound is ofmost use.
Severity of
COVID-19–related
lung injury Typical sonographic characteristics Typical clinical characteristics
Pre-disease
tomoderate
Development of B-lineswhich begin to increase
in number anddistribution.
Thepleural line begins to become irregular.
Areaswith B-lines are adjacent to normal areas
of lung sliding andA-lines. These are ‘skip
lesions’or ‘spared areas’.
Small (~1 cm) consolidations.
Respiratory rate > 30min1.
Oxygen saturations ≤93%on roomair.
The need for supplemental oxygen.
Lung tissue begins to lose aeration.
Severe B-lines continue to increase in number anddistribution,
and begin to affect the upper and anterior areas
of the lungs.
B-lines becomecoalescent/confluent.
Small consolidations increase in number and size.
Oxygen saturations ≤ 93%on supplementary oxygen.
Clinical signs of respiratory distress.
The need for additional supplemental oxygenor
respiratory support.
Lung tissue is becomingprogressively de-aerated.
Critical Extensive coalescent B-lines affect the upper and
anterior areas of the lungs.
Significant small consolidations affect the upper and
anterior areas of the lungs.
Posterio-basal sections of the lungs have significant
bilateral alveolar interstitial syndromeprogressing to
consolidationwith orswithout air bronchograms.
Pleural effusions are small or rare unless the patient’s
fluid balance is high.
Likely to be or require invasivemechanical ventilation.
The need for a high fraction of inspiredoxygen.
Dependent areas of lung tissue havebecoming
non-aerated.
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Table 3 Pragmatic considerations for the upskilling the potential lung ultrasoundworkforce.
Previous experience of
lungultrasound
Experienced in the use of
other formsof
ultrasound imaging
No previous ultrasound
imagingexperience
Pre-existing
skills and
knowledge
Foundationphysics
Probe handling
Imageoptimisation
Familiarity with normal and
pathological imaging
Reportingof lung
ultrasound findings
Clinical applicationof lung
ultrasound
Foundation physics
Probe handling
Imagingoptimisation
Strategies to address
suboptimal imaging
Reportingof ultrasound
imaging findings
Familiaritywith clinical
management of critically
ill patient
Skills and
experience
required
Strategies to address
suboptimal imaging,
for example, high BMI,
poor differentiation
of tissues andpatient
positioning
The key principles of
imaging in
patientswithCOVID-19
Familiarisationwith key
elements of lung imaging
Familiaritywith normal and
pathological imaging
Strategies to address
suboptimal imaging, for
example ,
high BMI, poor
differentiationof tissues
and
patient positioning
Reportingof lung
ultrasound findings
Awareness of clinical
application of lung
ultrasound
The key principles of
imaging in patients with
COVID-19
Foundationphysics
Probe handling
Imagingoptimisation
Familiarisationwith key
elements of lung
imaging
Familiaritywith normal
andpathological
imaging
Strategies to address
suboptimal imaging, for
example, high BMI, poor
differentiation of tissues
andpatient positioning
Reportingof lung
ultrasound findings
Clinical application of
lung ultrasound imaging
findings
The key principles of
imaging in patientswith
COVID-19
Support required Existing lung ultrasound
practitioner for directly
supervised scanning
experience.
Subsequently as option
for secondopinion
Existing lungultrasound
practitioner or generic
sonography educator to
teach lung ultrasound
technique. Existing lung
ultrasoundpractitioner
for directly supervised
scanning experience.
Subsequently as option for
secondopinion.
Generic sonography
educator for foundations
of ultrasound, including
‘hands-on’ support.
Existing lung ultrasound
practitioner or generic
sonography educator to
teach lungultrasound
technique.
Existing lung ultrasound
practitioner for directly
supervised scanning
experience.
Subsequently as option
for secondopinion
Priority for training High – the limited input
required supports rapid
progression to the
frontline of COVID-19
imaging
Medium –will progress
more quickly than those
with noprevious
ultrasound imaging
experience.
Themoderate input
required supports
progression
to the frontline of COVID-
19 imaging
Low –more extensive
training required as
comparedwith other
workforce groups.
Clinical knowledge
means these individuals
could becomeextremely
valuable in themedium
to long term.
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Upskilling the potential lung
ultrasoundworkforce
Alongside the existing lung ultrasound workforce, the
potential lung ultrasound workforce will likely prove vital in
meeting the unprecedented demand on clinical services.
These potential new operators include: those with previous
lung ultrasound experience; those with alternate ultrasound
imaging experience; and those with no previous ultrasound
imaging experience. There should be a commitment to
ensure that while point-of-care ultrasound may have a
focused remit, the standards of education and
demonstrable competency are identical to those in a
traditional imaging setting. However, given the
extraordinary pressures on clinical services and the highly
valuable role that lung ultrasound may play in this
pandemic, we present pragmatic considerations for
upskilling the potential lung ultrasoundworkforce (Table 3).
Nonetheless, in relation to all aspects of lung ultrasound,
healthcare service providers and individual practitioners are
reminded of their responsibility to provide the highest
standards of clinical care. Key differences between the
activities of existing lung ultrasound practitioners and
potential lung ultrasound practitioners are proposed
(Table 4).
In the context of a respiratory pandemic, we advocate
for a balance of professional rigour and pragmatism [39].
This includes taking account of local and national clinical
governance considerations, although in all cases it is the
operators’ responsibility to ensure these are addressed.
Considerations of professional indemnity and registration
must frame all decisions. For qualified medical doctors in
the UK, professional indemnity and registration are unlikely
to present barriers to lung ultrasound use. For
physiotherapists in the UK with Professional and Public
Liability through the Chartered Society of Physiotherapy,
use of lung ultrasound (where professional expertise has
been developed and maintained) as an adjunct to
physiotherapy assessment and treatment is permissible.
Other potential operators (e.g. respiratory nurses,
radiographer sonographers, point-of-care sonographers,
etc.) should consult their professional indemnity and
registration bodies. Operators both within and outside of
the UK should consult their professional indemnity and
registration bodies in the first instance.
Other governance considerations include agreement
with members of the care pathway (both upstream and
downstream), their employer and local managers. Where
professional indemnity and registration considerations
have been addressed, it is hoped that ‘local’ elements could
be readily negotiated. However, it is key to ensure that the
individual or profession only operates within their defined
and permissible scope of practice – and that the limitations
of this are explicitly communicated [40]. Lung ultrasound
practitioners require: access to equipment of suitable
quality to generate and store meaningful images [41];
training with appropriate clinical support; clear lines of
accountability; systems to report unexpected findings; and
absolute clarity regarding decision-making based upon
Table 4 Key differences between the activities of existing lung ultrasound practitioners and potential lung ultrasound
practitioners.
Existing lungultrasoundpractitioner Potential lungultrasoundworkforce
Core role inCOVID-19 imaging Identification of sonographic
characteristics of COVID-19pathology
Support clinical decision-making.
Support the ‘potential lung ultrasound
workforce’
Identification of sonographic characteristics of
COVID-19 pathology
Communicate findings to support clinical
decisionmaking.
Level of ‘sonographic autonomy’ High – able to provide ‘stand-alone’
sonographic interpretation
Initially low – requires verification of imaging
Progress tomoderate –discussion of scan
findings to inform clinical decision-making.
Progress to ability to provide ‘stand-alone’
sonographic interpretation in non-complex
cases
Additional imagingmechanisms Where time allows, use the 12-zone lung
ultrasound score (scale of 0–36)
None
Differential sonographic diagnosis Identification of sonographic
characteristics of COVID-19 as part of
initial triage anddiagnosis
Differential sonographic diagnoses of
pneumothorax or pleural effusion
None
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imaging findings. Although we encourage pragmatism, a
clinician who has received no training and does not have
access to mentorship in the workplace clearly should not be
attempting to use this imagingmodality.
Conclusion
Amidst a global respiratory pandemic, lung ultrasound may
have a key role to play in the clinical management of
patients with COVID-19–associated lung injury. Our clinical
recommendations provide support for existing operators
and describe how the current lung ultrasound workforce
may be expanded. Future work should focus on adding to
the very limited evidence base for these clinical
recommendations and the integration of lung ultrasound
into clinical care pathways. The pragmatic mechanisms
outlined in this review may mobilise a whole new lung
ultrasound workforce. One legacy of the current pandemic
is likely to be the expansion of lung ultrasound use and
expertise within the UK and beyond. Once the healthcare
landscape returns to something approximating more
normal circumstances, implementation of frameworks to
support consolidation of lung ultrasound skills and
competency are advocated.
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